Provided By GlobeNewswire
Last update: May 29, 2025
SASKATOON, Saskatchewan, May 29, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the filing on SEDAR+ of its unaudited financial statements together with associated MD&A for the first quarter ending March 31, 2025 as well as the execution of non-binding letters of intent to acquire four pharmacies.
Read more at globenewswire.com